Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 191

1.

Cost-effectiveness analysis of low-dose direct oral anticoagulant (DOAC) for the prevention of cancer-associated thrombosis in the United States.

Li A, Carlson JJ, Kuderer NM, Schaefer JK, Li S, Garcia DA, Khorana AA, Carrier M, Lyman GH.

Cancer. 2020 Jan 30. doi: 10.1002/cncr.32724. [Epub ahead of print]

PMID:
31999844
2.

RNA expression and risk of venous thromboembolism in lung cancer.

Sussman TA, Abazeed ME, McCrae KR, Khorana AA.

Res Pract Thromb Haemost. 2019 Dec 27;4(1):117-123. doi: 10.1002/rth2.12284. eCollection 2020 Jan.

3.

Venous thromboembolism risk with contemporary lenalidomide-based regimens despite thromboprophylaxis in multiple myeloma: A systematic review and meta-analysis.

Chakraborty R, Bin Riaz I, Malik SU, Marneni N, Mejia Garcia A, Anwer F, Khorana AA, Rajkumar SV, Kumar S, Murad MH, Wang Z, Khan SU, Majhail NS.

Cancer. 2020 Jan 8. doi: 10.1002/cncr.32682. [Epub ahead of print]

PMID:
31913498
4.

Healthcare resource utilization and costs associated with venous thromboembolism recurrence in patients with cancer.

Khorana AA, McCrae KR, Milentijevic D, Laliberté F, Lejeune D, Crivera C, Lefebvre P.

J Med Econ. 2020 Jan 11:1-7. doi: 10.1080/13696998.2019.1703190. [Epub ahead of print]

PMID:
31818164
5.

Clinical outcomes of isolated distal deep vein thrombosis versus proximal venous thromboembolism in cancer patients: The Cleveland Clinic experience.

Poudel SK, Park DY, Jia X, Wilks M, Pinkava V, O'Brien M, Tripp B, Song JM, McCrae KR, Khorana AA, Angelini DE.

J Thromb Haemost. 2019 Dec 6. doi: 10.1111/jth.14700. [Epub ahead of print]

PMID:
31808607
6.

Measuring Quality.

Khorana MM, Khorana AA.

JAMA. 2019 Dec 3;322(21):2077-2078. doi: 10.1001/jama.2019.18730. No abstract available.

PMID:
31794628
7.

Rethinking the approach to thrombosis in patients with cancer.

Khorana AA.

Vasc Med. 2019 Nov 13:1358863X19886354. doi: 10.1177/1358863X19886354. [Epub ahead of print] No abstract available.

PMID:
31718489
8.

Modeling Complexity: The Case of Cancer-Related Venous Thromboembolism.

Khorana AA.

Thromb Haemost. 2019 Nov;119(11):1713-1715. doi: 10.1055/s-0039-1700543. Epub 2019 Oct 30. No abstract available.

PMID:
31665801
9.

2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.

Farge D, Frere C, Connors JM, Ay C, Khorana AA, Munoz A, Brenner B, Kakkar A, Rafii H, Solymoss S, Brilhante D, Monreal M, Bounameaux H, Pabinger I, Douketis J; International Initiative on Thrombosis and Cancer (ITAC) advisory panel.

Lancet Oncol. 2019 Oct;20(10):e566-e581. doi: 10.1016/S1470-2045(19)30336-5. Epub 2019 Sep 3. Review.

PMID:
31492632
10.

Venous thromboembolism in breast cancer patients receiving cyclin-dependent kinase inhibitors.

Gervaso L, Montero AJ, Jia X, Khorana AA.

J Thromb Haemost. 2020 Jan;18(1):162-168. doi: 10.1111/jth.14630. Epub 2019 Sep 18.

PMID:
31479568
11.

Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline.

Palta M, Godfrey D, Goodman KA, Hoffe S, Dawson LA, Dessert D, Hall WA, Herman JM, Khorana AA, Merchant N, Parekh A, Patton C, Pepek JM, Salama JK, Tuli R, Koong AC.

Pract Radiat Oncol. 2019 Sep - Oct;9(5):322-332. doi: 10.1016/j.prro.2019.06.016.

PMID:
31474330
12.

Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: A systematic review and meta-analysis.

Li A, Kuderer NM, Garcia DA, Khorana AA, Wells PS, Carrier M, Lyman GH.

J Thromb Haemost. 2019 Dec;17(12):2141-2151. doi: 10.1111/jth.14613. Epub 2019 Sep 17.

PMID:
31420937
13.

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update.

Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AYY, Arcelus JI, Wong SL, Balaban EP, Flowers CR, Francis CW, Gates LE, Kakkar AK, Levine MN, Liebman HA, Tempero MA, Lyman GH, Falanga A.

J Clin Oncol. 2020 Feb 10;38(5):496-520. doi: 10.1200/JCO.19.01461. Epub 2019 Aug 5.

PMID:
31381464
14.

The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH.

Wang TF, Zwicker JI, Ay C, Pabinger I, Falanga A, Antic D, Noble S, Khorana AA, Carrier M, Meyer G.

J Thromb Haemost. 2019 Oct;17(10):1772-1778. doi: 10.1111/jth.14564. Epub 2019 Jul 28. No abstract available.

PMID:
31353841
15.

Risks and Benefits of Anticoagulation in Cancer and Noncancer Patients.

Park DY, Khorana AA.

Semin Thromb Hemost. 2019 Sep;45(6):629-637. doi: 10.1055/s-0039-1693474. Epub 2019 Jul 26. Review.

PMID:
31350735
16.

Predicting outcomes in patients with cancer and atrial fibrillation.

Gutierrez A, Patell R, Rybicki L, Khorana AA.

Ther Adv Cardiovasc Dis. 2019 Jan-Dec;13:1753944719860676. doi: 10.1177/1753944719860676.

17.

Risk of Thrombosis in Cancer: Clinical Factors and Role of Primary Prophylaxis.

Roopkumar J, Khorana AA.

Cancer Treat Res. 2019;179:55-68. doi: 10.1007/978-3-030-20315-3_4.

PMID:
31317480
18.

Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update Summary.

Khorana AA, McKernin SE, Katz MHG.

J Oncol Pract. 2019 Aug;15(8):454-457. doi: 10.1200/JOP.19.00253. Epub 2019 Jul 15. No abstract available.

PMID:
31306038
19.

Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update.

Khorana AA, McKernin SE, Berlin J, Hong TS, Maitra A, Moravek C, Mumber M, Schulick R, Zeh HJ, Katz MHG.

J Clin Oncol. 2019 Aug 10;37(23):2082-2088. doi: 10.1200/JCO.19.00946. Epub 2019 Jun 10.

PMID:
31180816
20.

Preventing Venous Thromboembolism in Patients with Cancer. Reply.

Khorana AA, Mones J, Soff GA.

N Engl J Med. 2019 May 30;380(22):2181. doi: 10.1056/NEJMc1904003. No abstract available.

PMID:
31141646
21.

Healthcare resource utilization and costs associated with venous thromboembolism in cancer patients treated with anticoagulants.

Streiff M, Milentijevic D, McCrae KR, Laliberté F, Lejeune D, Lefebvre P, Schein J, Khorana AA.

J Med Econ. 2019 Nov;22(11):1134-1140. doi: 10.1080/13696998.2019.1620752. Epub 2019 Jun 12.

PMID:
31106638
22.

Implementation of an electronic medical record tool for early detection of deep vein thrombosis in the ambulatory oncology setting.

Kunapareddy G, Switzer B, Jain P, Conces M, Chen YW, Patel B, Patel S, Pinnamaneni P, Pohlman B, Angelini DE, McCrae KR, Khorana AA.

Res Pract Thromb Haemost. 2019 Jan 28;3(2):226-233. doi: 10.1002/rth2.12176. eCollection 2019 Apr.

23.

Bleeding incidence and risk factors among cancer patients treated with anticoagulation.

Angelini DE, Radivoyevitch T, McCrae KR, Khorana AA.

Am J Hematol. 2019 Jul;94(7):780-785. doi: 10.1002/ajh.25494. Epub 2019 May 16.

PMID:
31006890
24.

Time to surgery and its impact on survival in patients with endometrial cancer: A National cancer database study.

AlHilli MM, Elson P, Rybicki L, Khorana AA, Rose PG.

Gynecol Oncol. 2019 Jun;153(3):511-516. doi: 10.1016/j.ygyno.2019.03.244. Epub 2019 Apr 15.

PMID:
31000472
25.

Correction: Time to initial cancer treatment in the United States and association with survival over time: An observational study.

Khorana AA, Tullio K, Elson P, Pennell NA, Grobmyer SR, Kalady MF, Raymond D, Abraham J, Klein EA, Walsh RM, Monteleone EE, Wei W, Hobbs B, Bolwell BJ.

PLoS One. 2019 Apr 4;14(4):e0215108. doi: 10.1371/journal.pone.0215108. eCollection 2019.

26.

Does Sidedness Matter in Unresectable Colorectal Cancer?

Kamath SD, Khorana AA.

Ann Surg Oncol. 2019 Jun;26(6):1588-1591. doi: 10.1245/s10434-019-07315-w. Epub 2019 Mar 18. No abstract available.

PMID:
30887371
27.

A Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer.

Ramanathan RK, Thomas GW, Khorana AA, Shah S, Zhou C, Wong S, Cole G Jr, James D, Gabrail NY.

Oncology. 2019;96(4):217-222. doi: 10.1159/000495988. Epub 2019 Mar 7.

28.

Time to initial cancer treatment in the United States and association with survival over time: An observational study.

Khorana AA, Tullio K, Elson P, Pennell NA, Grobmyer SR, Kalady MF, Raymond D, Abraham J, Klein EA, Walsh RM, Monteleone EE, Wei W, Hobbs B, Bolwell BJ.

PLoS One. 2019 Mar 1;14(3):e0213209. doi: 10.1371/journal.pone.0213209. eCollection 2019. Erratum in: PLoS One. 2019 Apr 4;14(4):e0215108.

29.

If Trousseau had a stroke.

Khorana AA.

Blood. 2019 Feb 21;133(8):769-770. doi: 10.1182/blood-2019-01-894261. No abstract available.

PMID:
30792219
30.

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.

Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T, Streiff MB, Garcia DA, Liebman HA, Belani CP, O'Reilly EM, Patel JN, Yimer HA, Wildgoose P, Burton P, Vijapurkar U, Kaul S, Eikelboom J, McBane R, Bauer KA, Kuderer NM, Lyman GH; CASSINI Investigators.

N Engl J Med. 2019 Feb 21;380(8):720-728. doi: 10.1056/NEJMoa1814630.

PMID:
30786186
31.

Duration of anticoagulant therapy and VTE recurrence in patients with cancer.

Khorana AA, McCrae KR, Milentijevic D, Fortier J, Nelson WW, Laliberté F, Crivera C, Lefebvre P, Schein J.

Support Care Cancer. 2019 Oct;27(10):3833-3840. doi: 10.1007/s00520-019-4661-3. Epub 2019 Feb 8.

32.

Anticoagulation in Cancer Patients: a Summary of Pitfalls to Avoid.

Patel HK, Khorana AA.

Curr Oncol Rep. 2019 Feb 4;21(2):18. doi: 10.1007/s11912-019-0767-5. Review.

PMID:
30715628
33.

Evaluating Susceptibility to Pancreatic Cancer: ASCO Clinical Practice Provisional Clinical Opinion Summary.

Stoffel EM, McKernin SE, Khorana AA.

J Oncol Pract. 2019 Feb;15(2):108-111. doi: 10.1200/JOP.18.00629. Epub 2018 Dec 27. No abstract available.

PMID:
30589608
34.

The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation.

Khorana AA, McCrae K, Milentijevic D, McCormick N, Laliberté F, Crivera C, Lefebvre P, Lejeune D, Rozjabek H, Schein J, Streiff MB.

Am J Hematol. 2019 Feb;94(2):E58-E61. doi: 10.1002/ajh.25361. Epub 2018 Dec 18. No abstract available.

35.

Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.

Stoffel EM, McKernin SE, Brand R, Canto M, Goggins M, Moravek C, Nagarajan A, Petersen GM, Simeone DM, Yurgelun M, Khorana AA.

J Clin Oncol. 2019 Jan 10;37(2):153-164. doi: 10.1200/JCO.18.01489. Epub 2018 Nov 20.

PMID:
30457921
36.

Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic review.

Samuelson Bannow BR, Lee AYY, Khorana AA, Zwicker JI, Noble S, Ay C, Carrier M.

Res Pract Thromb Haemost. 2018 Jun 19;2(4):664-669. doi: 10.1002/rth2.12111. eCollection 2018 Oct.

37.

Artificial intelligence for cancer-associated thrombosis risk assessment - Author's reply.

Khorana AA.

Lancet Haematol. 2018 Sep;5(9):e391-e392. doi: 10.1016/S2352-3026(18)30118-2. No abstract available.

PMID:
30172344
38.

Adjuvant Treatment in Potentially Curable Pancreatic Cancer: Need to Include Tumor Location in the Equation?

Mukhija D, Sohal DPS, Khorana AA.

Pancreas. 2018 Sep;47(8):e50-e52. doi: 10.1097/MPA.0000000000001125. No abstract available.

PMID:
30113430
39.

Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH.

Khorana AA, Noble S, Lee AYY, Soff G, Meyer G, O'Connell C, Carrier M.

J Thromb Haemost. 2018 Sep;16(9):1891-1894. doi: 10.1111/jth.14219. Epub 2018 Jul 19. No abstract available.

PMID:
30027649
40.

Do patients with pancreatic body or tail cancer benefit from adjuvant therapy?A cohort study.

Sohal DPS, Tullio K, Khorana AA.

Surg Oncol. 2018 Jun;27(2):245-250. doi: 10.1016/j.suronc.2018.05.008. Epub 2018 May 7.

PMID:
29937178
41.

An answer to "anticoagulant treatment of cancer-associated venous thromboembolism: Interpreting real-world data with caution".

Streiff MB, Milentijevic D, McCrae K, Yannicelli D, Lejeune D, Nelson WW, Laliberté F, Crivera C, Lefebvre P, Schein J, Khorana AA.

Am J Hematol. 2018 Sep;93(9):E225-E227. doi: 10.1002/ajh.25165. Epub 2018 Aug 7. No abstract available.

42.

Simplicity versus complexity: an existential dilemma as risk tools evolve.

Khorana AA.

Lancet Haematol. 2018 Jul;5(7):e273-e274. doi: 10.1016/S2352-3026(18)30067-X. Epub 2018 Jun 7. No abstract available. Erratum in: Lancet Haematol. 2018 Jun 15;:.

43.

Prevalence of Venous Thromboembolism Diagnosed in Emergency Department Visits by Cancer Patients and Associated Healthcare Resource Utilization in the United States.

Chen YW, Wang MJ, Khorana AA.

Am J Hematol. 2018 May 23. doi: 10.1002/ajh.25148. [Epub ahead of print] No abstract available.

44.

Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology.

Mohile SG, Dale W, Somerfield MR, Schonberg MA, Boyd CM, Burhenn PS, Canin B, Cohen HJ, Holmes HM, Hopkins JO, Janelsins MC, Khorana AA, Klepin HD, Lichtman SM, Mustian KM, Tew WP, Hurria A.

J Clin Oncol. 2018 Aug 1;36(22):2326-2347. doi: 10.1200/JCO.2018.78.8687. Epub 2018 May 21.

45.

Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH.

Samuelson Bannow BT, Lee A, Khorana AA, Zwicker JI, Noble S, Ay C, Carrier M.

J Thromb Haemost. 2018 Jun;16(6):1246-1249. doi: 10.1111/jth.14015. Epub 2018 May 8. No abstract available.

PMID:
29737593
46.

Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or Vomiting.

Riess H, Ay C, Bauersachs R, Becattini C, Beyer-Westendorf J, Cajfinger F, Chau I, Cohen AT, Khorana AA, Maraveyas A, Renni M, Young AM.

Oncologist. 2018 Jul;23(7):822-839. doi: 10.1634/theoncologist.2017-0473. Epub 2018 Apr 12. Review.

47.

Renal Impairment, Recurrent Venous Thromboembolism and Bleeding in Cancer Patients with Acute Venous Thromboembolism-Analysis of the CATCH Study.

Bauersachs R, Lee AYY, Kamphuisen PW, Meyer G, Janas MS, Jarner MF, Khorana AA; CATCH Investigators.

Thromb Haemost. 2018 May;118(5):914-921. doi: 10.1055/s-0038-1641150. Epub 2018 Apr 4.

PMID:
29618162
48.

Multidisciplinary Conference and Clinical Management of Rectal Cancer.

Karagkounis G, Stocchi L, Lavery IC, Liska D, Gorgun E, Veniero J, Plesec T, Amarnath S, Khorana AA, Kalady MF.

J Am Coll Surg. 2018 May;226(5):874-880. doi: 10.1016/j.jamcollsurg.2018.01.056. Epub 2018 Mar 23.

PMID:
29580878
49.

Clinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study.

Kamphuisen PW, Lee AYY, Meyer G, Bauersachs R, Janas MS, Jarner MF, Khorana AA; CATCH Investigators.

J Thromb Haemost. 2018 Jun;16(6):1069-1077. doi: 10.1111/jth.14007. Epub 2018 Apr 17.

PMID:
29573330
50.

Treatment Challenges in Venous Thromboembolism: An Appraisal of Rivaroxaban Studies.

Khorana AA, Weitz JI.

Thromb Haemost. 2018 May;118(S 01):S23-S33. doi: 10.1160/TH17-09-0681. Epub 2018 Mar 22. Review.

PMID:
29566417

Supplemental Content

Loading ...
Support Center